Currently out of the existing stock ratings of Andrew Cooper, 162 are a BUY (91.01%), 16 are a HOLD (8.99%).

Andrew Cooper

Work Performance Price Targets & Ratings Chart

Analyst Andrew Cooper, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 56.45% that have a potential upside of 21.62% achieved within 230 days.

Andrew Cooper’s has documented 335 price targets and ratings displayed on 24 stocks. The coverage is on Healthcare, Basic Materials, Industrials sectors.

Most recent stock forecast was given on HAE, Haemonetics at 03-Sep-2026.

Wall Street Analyst Andrew Cooper

Analyst best performing recommendations are on NTRA (NATERA).
The best stock recommendation documented was for GH (GUARDANT HEALTH) at 7/31/2025. The price target of $61 was fulfilled within 21 days with a profit of $20.02 (48.85%) receiving and performance score of 23.26.

Average potential price target upside

CDNA Caredx CVET Covetrus EXAS EXACT Sciences NEO NeoGenomics NVTA Invitae Corp OSUR OraSure Technologies PROG Progenity QDEL Quidel VCYT Veracyte AVTR Avantor HAE Haemonetics HOLX Hologic LMDX LumiraDx Ltd MYGN Myriad Genetics NTRA Natera DHR Danaher GH Guardant Health TMO Thermo Fisher Scientific RVTY Revvity AZTA Azenta FLGT Fulgent Genetics ITGR Integer Holdings Corp HSKA Heska NVT nVent Electric PLC

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 20-Jul-2021

$74

$6.85 (10.20%)

$60

9 days ago
(24-Sep-2026)

10/12 (83.33%)

$12.63 (20.58%)

214

Hold Since 26-Feb-2021

$46

$-21.15 (-31.50%)

$25

2 months 2 days ago
(31-Jul-2026)

11/11 (100%)

$2.29 (5.24%)

232

Hold Since 15-Dec-2025

$21

$-7.82 (-27.13%)

$18

7 months 7 days ago
(25-Feb-2026)

4/4 (100%)

$2.54 (13.76%)

32

Buy Since 08-Oct-2024

$22

$-6.82 (-23.66%)

$22

1 years 9 days ago
(23-Sep-2025)

5/11 (45.45%)

$6.43 (41.30%)

130

Buy Since 17-Apr-2024

$40

$11.18 (38.79%)

$40

1 years 4 months 27 days ago
(05-May-2025)

0/3 (0%)

$24.83 (163.68%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Andrew Cooper most bullish on?

Potential upside of $20.32 has been obtained for HAE (HAEMONETICS)

What Year was the first public recommendation made by Andrew Cooper?

On 2014
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?